Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 59 min ago
PreprintCC BYmedRxiv

Peritumoral SULF1 Transcript Signal Is Associated with Disease-Specific Survival in Oral Squamous Cell Carcinoma

  1. 1Georgetown University Medical Center

Abstract

The prognostic relevance of peritumoral SULF1 transcript signal in oral squamous cell carcinoma (OSCC) is unclear. We assembled a retrospective cohort of 133 patients with 218 primary-site tissue-microarray cores; 131 patients had evaluable boundary features. Multiplex fluorescence imaging combined RNAscope SULF1, CK-pan, and DAPI. Tumor-stroma boundaries were annotated with the SULF1 channel hidden. We screened 50 exported boundary features across cumulative stromal bands of 35-300 m against recurrence-free survival (RFS), overall survival (OS), and disease-specific survival (DSS), with false-discovery-rate correction. The strongest DSS association was signal SD within 150 m (n = 107; 23 disease-specific deaths; HR = 2.20 per SD; 95% CI, 1.64-2.94; q = 2.1 x 10-). In 50 repeated 5-fold cross-validations with feature selection repeated within training folds, adding a boundary feature to AJCC stage increased mean held-out DSS c-index from 0.613 to 0.754 ({Delta}C = +0.141; 2.5th-97.5th percentiles across repeats, +0.105 to +0.192). These percentiles describe split variability, not confidence intervals. The 150-m SD feature was selected in 39.2% of DSS training folds. The DSS association persisted after adjustment for mean signal, although the measurements were strongly correlated. Peritumoral SULF1 signal dispersion was associated with outcome beyond an ordinal AJCC-stage model; independent validation is required.

Related

  1. Magnetic resonance imaging-based radiomics for predicting P53-mutated hepatocellular carcinoma: intratumoral and peritumoral analysis
    Jingfei Weng, Dinghua Yao, Qihu Zeng +3
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Impact of Organ-Specific Severe Immune-Related Adverse Events on Long-Term Survival and Treatment Transitions in Metastatic Renal Cell Carcinoma: A 5-Year Multicenter Multistate Analysis.
    Yoshihiko Tasaki, Kazumasa Sato, Shuzo Hamamoto +17
    Cancer medicinePeer-reviewedCC BY-NCFull textOncologyEurope PMCDOAJ
  3. Cancer type-specific profiling of chromatin regulator mutations identifies recurrent and co-occurring gene sets associated with improved survival following immune checkpoint therapy
    D. Bukovec, M. Gjorgjievska, S. Kocevska +5
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  4. Age-specific survival after breast conservation versus mastectomy for ductal carcinoma in situ of the breast.
    Jana de Boniface, Robert Szulkin, Per Karlsson +1
    Breast cancer research and treatmentPeer-reviewedCC BYFull textOncologyEurope PMC
  5. CT habitat and peritumoral radiomics for predicting progression after repeat TACE in hepatocellular carcinoma: a multicenter study
    Fei Wang, Yue Hu, Zhong-Xing Shi +11
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossrefEurope PMCPMC
BibTeX
@misc{furletti2026peritumoral,
  title = {{Peritumoral SULF1 Transcript Signal Is Associated with Disease-Specific Survival in Oral Squamous Cell Carcinoma}},
  author = {G. Furletti and T. C. Guerrero and E. Schrom and B. Davidson and B. Kallakury and R. Goldman},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.09.26364914},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.09.26364914v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Peritumoral SULF1 Transcript Signal Is Associated with Disease-Specific Survival in Oral Squamous Cell Carcinoma
AU  - G. Furletti
AU  - T. C. Guerrero
AU  - E. Schrom
AU  - B. Davidson
AU  - B. Kallakury
AU  - R. Goldman
PY  - 2026
DA  - 2026/10/09
PB  - medRxiv
DO  - 10.64898/2026.10.09.26364914
UR  - https://www.medrxiv.org/content/10.64898/2026.10.09.26364914v1
AB  - The prognostic relevance of peritumoral SULF1 transcript signal in oral squamous cell carcinoma (OSCC) is unclear. We assembled a retrospective cohort of 133 patients with 218 primary-site tissue-microarray cores; 131 patients had evaluable boundary features. Multiplex fluorescence imaging combined RNAscope SULF1, CK-pan, and DAPI. Tumor-stroma boundaries were annotated with the SULF1 channel hidden. We screened 50 exported boundary features across cumulative stromal bands of 35-300 m against recurrence-free survival (RFS), overall survival (OS), and disease-specific survival (DSS), with false-discovery-rate correction. The strongest DSS association was signal SD within 150 m (n = 107; 23 disease-specific deaths; HR = 2.20 per SD; 95% CI, 1.64-2.94; q = 2.1 x 10-). In 50 repeated 5-fold cross-validations with feature selection repeated within training folds, adding a boundary feature to AJCC stage increased mean held-out DSS c-index from 0.613 to 0.754 ({Delta}C = +0.141; 2.5th-97.5th percentiles across repeats, +0.105 to +0.192). These percentiles describe split variability, not confidence intervals. The 150-m SD feature was selected in 39.2% of DSS training folds. The DSS association persisted after adjustment for mean signal, although the measurements were strongly correlated. Peritumoral SULF1 signal dispersion was associated with outcome beyond an ordinal AJCC-stage model; independent validation is required.
ER  -